Vikas Prasad, MD

Radiologist

Primary Academic Title

Associate Professor of Radiology, Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Director, Clinical Theranostics, WashU Medicine

Clinical Expertise

Nuclear medicine

Education

2001: MBBS, Mahatma Gandhi Memorial Medical College, Indore, Devi Ahilya Vishwavidyalaya, India

Training

2001 - 2003: Resident, nuclear medicine, Institute of Nuclear Medicine and Allies Sciences, Delhi
2003 - 2005: Resident, nuclear medicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
2006 - 2007: Clinical research associate, nuclear medicine, Zentralklinik Bad Berka, Germany
2007 - 2009: Resident, nuclear medicine, Zentralklinik Bad Berka

Selected Research Publications

Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management.

Koumarianou A, Derks J, Tsoli M, [...] Prasad V, [...] Durand A
Endocr Rev 2026

Advances in Molecular Imaging for Neuroendocrine Neoplasms.

Girod B, Prasad V
Cancers (Basel) 2025

Theranostics in Lung Neuroendocrine Tumors.

Dev ID, Puranik AD, Trikalinos NA, [...] Prasad V
Semin Nucl Med 2025

Frontiers in radiopharmaceuticals for neuroendocrine tumors.

Puranik AD, Dev ID, Prasad V
J Neuroendocrinol 2025

Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force.

Prasad V, Koumarianou A, Denecke T, [...] Ambrosini V
J Neuroendocrinol 2025

Asymmetric 18F-FDG Uptake in Oropharynx-PET Parameters to Minimize Unnecessary Interventions.

Prasad V, Parihar AS
JAMA Otolaryngol Head Neck Surg 2024

Use of approved Lu-177 radiopharmaceuticals in patients with end-stage renal disease: A review of the literature and proposed treatment algorithm.

Trikalinos NA, Kim H, Vijayan A, Amurao M, Prasad V
J Neuroendocrinol 2024

Use and perceived utility of [18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.

Ambrosini V, Caplin M, Castaño JP, [...] Prasad V
J Neuroendocrinol 2024

New horizon of radiopharmaceuticals in management of neuroendocrine tumors.

Haq A, Rayamajhi S, Ponisio MR, Prasad V
Best Pract Res Clin Endocrinol Metab 2023

Optimization of Radiolabeling of a [90Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation.

Winter G, Hamp-Goldstein C, Fischer G, [...] Prasad V
Cancers (Basel) 2023

View All Publications

Contact Information

Center for Advanced Medicine at Siteman Cancer Center

4921 Parkview Place
Saint Louis, MO 63110

Request an appointment